{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:51:06Z","timestamp":1788609066282,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03839-0","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:43:51Z","timestamp":1737161031000},"page":"3100-3109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Azathioprine and risk of non-melanoma skin cancers in organ transplant recipients: a systematic review and update meta-analysis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8968-8190","authenticated-orcid":false,"given":"Michele","family":"Kreuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0316-8047","authenticated-orcid":false,"given":"Jorge Cavalcanti Orestes","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3006-5489","authenticated-orcid":false,"given":"Luis Eduardo Rodrigues","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-6461","authenticated-orcid":false,"given":"Maria Eduarda","family":"Cavalcanti Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5465-6795","authenticated-orcid":false,"given":"Lara Eduardo","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-6929","authenticated-orcid":false,"given":"Francinny Alves","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-8135","authenticated-orcid":false,"given":"Francisco Cezar Aquino","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"3839_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/ajt.13596","volume":"16","author":"AE Coghill","year":"2016","unstructured":"Coghill AE, Johnson LG, Berg D, et al. Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort. Am J Transplant. 2016;16:565\u201373. https:\/\/doi.org\/10.1111\/ajt.13596.","journal-title":"Am J Transplant"},{"key":"3839_CR2","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.canep.2011.12.002","volume":"36","author":"RN Oliveira Cobucci","year":"2012","unstructured":"Oliveira Cobucci RN, Saconato H, Lima PH, et al. Comparative incidence of cancer in HIV-AIDS patients and transplant recipients. Cancer Epidemiol. 2012;36:e69-73. https:\/\/doi.org\/10.1016\/j.canep.2011.12.002.","journal-title":"Cancer Epidemiol"},{"key":"3839_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(07)61050-2.","journal-title":"Lancet"},{"key":"3839_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.transproceed.2015.03.039","volume":"47","author":"B Aguiar","year":"2015","unstructured":"Aguiar B, Santos Amorim T, Rom\u00e3ozinho C, et al. Malignancy in kidney transplantation: a 25-year single-center experience in portugal. Transplant Proc. 2015;47:976\u201380. https:\/\/doi.org\/10.1016\/j.transproceed.2015.03.039.","journal-title":"Transplant Proc"},{"key":"3839_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/ejso.2001.1119","volume":"27","author":"JT Winkelhorst","year":"2001","unstructured":"Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol. 2001;27:409\u201313. https:\/\/doi.org\/10.1053\/ejso.2001.1119.","journal-title":"Eur J Surg Oncol"},{"key":"3839_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","volume":"10","author":"D Collett","year":"2010","unstructured":"Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant. 2010;10:1889\u201396. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03181.x.","journal-title":"Am J Transplant"},{"key":"3839_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"S Euvrard","year":"2003","unstructured":"Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681\u201391. https:\/\/doi.org\/10.1056\/NEJMra022137.","journal-title":"N Engl J Med"},{"key":"3839_CR8","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1126\/science.1114233","volume":"309","author":"P O\u2019Donovan","year":"2005","unstructured":"O\u2019Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871\u20134. https:\/\/doi.org\/10.1126\/science.1114233.","journal-title":"Science"},{"key":"3839_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2133.2008.08610.x","volume":"159","author":"CM Perrett","year":"2008","unstructured":"Perrett CM, Walker SL, O\u2019Donovan P, et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol. 2008;159:198\u2013204. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08610.x.","journal-title":"Br J Dermatol"},{"key":"3839_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00007890-198709000-00021","volume":"44","author":"GE Kelly","year":"1987","unstructured":"Kelly GE, Meikle W, Sheil AG. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation. 1987;44:429\u201334. https:\/\/doi.org\/10.1097\/00007890-198709000-00021.","journal-title":"Transplantation"},{"key":"3839_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c570","volume":"340","author":"MT van Leeuwen","year":"2010","unstructured":"van Leeuwen MT, Webster AC, McCredie MRE, et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ. 2010;340: c570. https:\/\/doi.org\/10.1136\/bmj.c570.","journal-title":"BMJ"},{"key":"3839_CR12","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2010.13036","volume":"140","author":"B Keller","year":"2010","unstructured":"Keller B, Braathen LR, Marti H-P, Hunger RE. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly. 2010;140: w13036. https:\/\/doi.org\/10.4414\/smw.2010.13036.","journal-title":"Swiss Med Wkly"},{"key":"3839_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1046\/j.1365-2133.2002.04976.x","volume":"147","author":"HM Ramsay","year":"2002","unstructured":"Ramsay HM, Fryer AA, Hawley CM, et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol. 2002;147:950\u20136. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04976.x.","journal-title":"Br J Dermatol"},{"key":"3839_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1067\/mjd.2002.125579","volume":"47","author":"D Berg","year":"2002","unstructured":"Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47:1\u201317. https:\/\/doi.org\/10.1067\/mjd.2002.125579.","journal-title":"J Am Acad Dermatol"},{"key":"3839_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrneph.2010.102","volume":"6","author":"I Rama","year":"2010","unstructured":"Rama I, Griny\u00f3 JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6:511\u20139. https:\/\/doi.org\/10.1038\/nrneph.2010.102.","journal-title":"Nat Rev Nephrol"},{"key":"3839_CR16","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891\u2013901. https:\/\/doi.org\/10.1001\/jama.2011.1592.","journal-title":"JAMA"},{"key":"3839_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.27765","volume":"132","author":"B Krynitz","year":"2013","unstructured":"Krynitz B, Edgren G, Lindel\u00f6f B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2013a Swedish population-based study. Int J Cancer. 2013;132:1429\u201338. https:\/\/doi.org\/10.1002\/ijc.27765.","journal-title":"Int J Cancer"},{"key":"3839_CR18","unstructured":"DeVita VT, Lawrence TS, Rosenberg SA (2015) DeVita, Hellman, and Rosenberg\u2019s cancer: Principles & practice of oncology: Tenth edition. In: DeVita, Hellman, and Rosenberg\u2019s Cancer: Principles & Practice of Oncology: Tenth Edition. Wolters Kluwer Health Adis (ESP), pp 1\u20132280"},{"key":"3839_CR19","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/cancers15153754","volume":"15","author":"JN Priantti","year":"2023","unstructured":"Priantti JN, Vilbert M, Madeira T, et al. Efficacy and Safety Of Rechallenge with BRAF\/MEK inhibitors in advanced melanoma patients: a systematic review and meta-analysis. Cancers (Basel). 2023;15:3754. https:\/\/doi.org\/10.3390\/cancers15153754.","journal-title":"Cancers (Basel)"},{"key":"3839_CR20","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/01.tp.0000120181.89206.54","volume":"77","author":"M Guba","year":"2004","unstructured":"Guba M, Graeb C, Jauch K-W, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation. 2004;77:1777\u201382. https:\/\/doi.org\/10.1097\/01.tp.0000120181.89206.54.","journal-title":"Transplantation"},{"key":"3839_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1432-2277.2006.00330.x","volume":"19","author":"HM Kauffman","year":"2006","unstructured":"Kauffman HM, Cherikh WS, McBride MA, et al. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int. 2006;19:607\u201320. https:\/\/doi.org\/10.1111\/j.1432-2277.2006.00330.x.","journal-title":"Transpl Int"},{"key":"3839_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1600-0625.2010.01213.x","volume":"20","author":"K-M Thoms","year":"2011","unstructured":"Thoms K-M, Kuschal C, Oetjen E, et al. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression. Exp Dermatol. 2011;20:232\u20136. https:\/\/doi.org\/10.1111\/j.1600-0625.2010.01213.x.","journal-title":"Exp Dermatol"},{"key":"3839_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.bjc.6604665","volume":"99","author":"CA Harwood","year":"2008","unstructured":"Harwood CA, Attard NR, O\u2019Donovan P, et al. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer. 2008;99:1276\u201384. https:\/\/doi.org\/10.1038\/sj.bjc.6604665.","journal-title":"Br J Cancer"},{"key":"3839_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/nar\/gkp070","volume":"37","author":"R Brem","year":"2009","unstructured":"Brem R, Li F, Karran P. Reactive oxygen species generated by thiopurine\/UVA cause irreparable transcription-blocking DNA lesions. Nucleic Acids Res. 2009;37:1951\u201361. https:\/\/doi.org\/10.1093\/nar\/gkp070.","journal-title":"Nucleic Acids Res"},{"key":"3839_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0625.2007.00651.x","volume":"17","author":"YGL de Graaf","year":"2008","unstructured":"de Graaf YGL, Rebel H, Elghalbzouri A, et al. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine. Exp Dermatol. 2008;17:349\u201355. https:\/\/doi.org\/10.1111\/j.1600-0625.2007.00651.x.","journal-title":"Exp Dermatol"},{"key":"3839_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1067\/mlc.2001.111469","volume":"137","author":"M Herman","year":"2001","unstructured":"Herman M, Weinstein T, Korzets A, et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med. 2001;137:14\u201320. https:\/\/doi.org\/10.1067\/mlc.2001.111469.","journal-title":"J Lab Clin Med"},{"key":"3839_CR27","first-page":"106","volume":"1","author":"I Penn","year":"1969","unstructured":"Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc. 1969;1:106\u201312.","journal-title":"Transplant Proc"},{"key":"3839_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jama.1977.03270290052028","volume":"237","author":"J Scharf","year":"1977","unstructured":"Scharf J, Nahir M, Eidelman S, et al. Carcinoma of the bladder with azathioprine therapy. JAMA. 1977;237:152.","journal-title":"JAMA"},{"key":"3839_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0140-6736(71)91384-5","volume":"1","author":"SA Schneck","year":"1971","unstructured":"Schneck SA, Penn I. De-novo brain tumours in renal-transplant recipients. Lancet. 1971;1:983\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(71)91384-5.","journal-title":"Lancet"},{"key":"3839_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"3839_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2046-4053-1-2","volume":"1","author":"A Booth","year":"2012","unstructured":"Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2. https:\/\/doi.org\/10.1186\/2046-4053-1-2.","journal-title":"Syst Rev"},{"key":"3839_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Systematic Reviews. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Systematic Reviews"},{"key":"3839_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.85940","volume":"2","author":"KKM Ahmed","year":"2011","unstructured":"Ahmed KKM, Al Dhubaib BE. Zotero: a bibliographic assistant to researcher. J Pharmacol Pharmacother. 2011;2:303\u20135. https:\/\/doi.org\/10.4103\/0976-500X.85940.","journal-title":"J Pharmacol Pharmacother"},{"key":"3839_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK-L Lo","year":"2014","unstructured":"Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45. https:\/\/doi.org\/10.1186\/1471-2288-14-45.","journal-title":"BMC Med Res Methodol"},{"key":"3839_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"3839_CR36","doi-asserted-by":"crossref","unstructured":"Page MJ, Higgins JP, Sterne JA (2019) Assessing risk of bias due to missing results in a synthesis. In: Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons, Ltd, pp 349\u2013374","DOI":"10.1002\/9781119536604.ch13"},{"key":"3839_CR37","doi-asserted-by":"publisher","first-page":"2023148","DOI":"10.1590\/1516-3180.2023.0148.R1.29112023","volume":"142","author":"\u00c9C Vieira","year":"2024","unstructured":"Vieira \u00c9C, Marcolino MS, Guedes ACM, et al. Frequency of skin diseases in renal transplant recipients and patients with chronic kidney disease in a tertiary center: a cross-sectional study. Sao Paulo Med J. 2024;142:2023148. https:\/\/doi.org\/10.1590\/1516-3180.2023.0148.R1.29112023.","journal-title":"Sao Paulo Med J"},{"key":"3839_CR38","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/ndt\/gfp425","volume":"25","author":"A Ingvar","year":"2010","unstructured":"Ingvar A, Smedby KE, Lindel\u00f6f B, et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant. 2010;25:2764\u201371. https:\/\/doi.org\/10.1093\/ndt\/gfp425.","journal-title":"Nephrol Dial Transplant"},{"key":"3839_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","volume":"24","author":"HJ Eisen","year":"2005","unstructured":"Eisen HJ, Kobashigawa J, Keogh A, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005;24:517\u201325. https:\/\/doi.org\/10.1016\/j.healun.2005.02.002.","journal-title":"J Heart Lung Transplant"},{"key":"3839_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1681\/ASN.2009101043","volume":"21","author":"MP Gallagher","year":"2010","unstructured":"Gallagher MP, Kelly PJ, Jardine M, et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol. 2010;21:852\u20138. https:\/\/doi.org\/10.1681\/ASN.2009101043.","journal-title":"J Am Soc Nephrol"},{"key":"3839_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3325\/cmj.2022.63.148","volume":"63","author":"N Ba\u0161i\u0107-Juki\u0107","year":"2022","unstructured":"Ba\u0161i\u0107-Juki\u0107 N, Borlini\u0107 T, Te\u0161anovi\u0107 D, et al. Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40 year retrospective study in Croatia. Croat Med J. 2022;63:148\u201355. https:\/\/doi.org\/10.3325\/cmj.2022.63.148.","journal-title":"Croat Med J"},{"key":"3839_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","volume":"37","author":"M Vos","year":"2018","unstructured":"Vos M, Plasmeijer EI, van Bemmel BC, et al. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation. J Heart Lung Transplant. 2018;37:853\u20139. https:\/\/doi.org\/10.1016\/j.healun.2018.03.012.","journal-title":"J Heart Lung Transplant"},{"key":"3839_CR43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","volume":"145","author":"JD Brewer","year":"2009","unstructured":"Brewer JD, Colegio OR, Phillips PK, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol. 2009;145:1391\u20136. https:\/\/doi.org\/10.1001\/archdermatol.2009.276.","journal-title":"Arch Dermatol"},{"key":"3839_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","volume":"61","author":"JN Bouwes Bavinck","year":"1996","unstructured":"Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland Australia. A follow-up study. Transplantation. 1996;61:715\u201321. https:\/\/doi.org\/10.1097\/00007890-199603150-00008.","journal-title":"Transplantation"},{"key":"3839_CR45","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/ndt\/gfp482","volume":"25","author":"KA Mackenzie","year":"2010","unstructured":"Mackenzie KA, Wells JE, Lynn KL, et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant. 2010;25:300\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfp482.","journal-title":"Nephrol Dial Transplant"},{"key":"3839_CR46","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1365-2133.2003.05740.x","volume":"149","author":"MJ Fuente","year":"2003","unstructured":"Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol. 2003;149:1221\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2003.05740.x.","journal-title":"Br J Dermatol"},{"key":"3839_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1590\/abd1806-4841.20164891","volume":"91","author":"A Pinho","year":"2016","unstructured":"Pinho A, Gouveia M, Cardoso JC, et al. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors. An Bras Dermatol. 2016;91:455\u201362. https:\/\/doi.org\/10.1590\/abd1806-4841.20164891.","journal-title":"An Bras Dermatol"},{"key":"3839_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000521","volume":"1","author":"ML Sanders","year":"2015","unstructured":"Sanders ML, Karnes JH, Denny JC, et al. Clinical and genetic factors associated with cutaneous squamous cell carcinoma in kidney and heart transplant recipients. Transplant Direct. 2015;1: e13. https:\/\/doi.org\/10.1097\/TXD.0000000000000521.","journal-title":"Transplant Direct"},{"key":"3839_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jaad.2021.07.065","volume":"86","author":"JR Dusendang","year":"2022","unstructured":"Dusendang JR, Carlson E, Lee DS, et al. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication. J Am Acad Dermatol. 2022;86:598\u2013606. https:\/\/doi.org\/10.1016\/j.jaad.2021.07.065.","journal-title":"J Am Acad Dermatol"},{"key":"3839_CR50","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-4632.2008.03711.x","volume":"47","author":"A Geusau","year":"2008","unstructured":"Geusau A, Dunkler D, Messeritsch E, et al. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol. 2008;47:918\u201325. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03711.x.","journal-title":"Int J Dermatol"},{"key":"3839_CR51","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","volume":"71","author":"CD Wimmer","year":"2007","unstructured":"Wimmer CD, Rentsch M, Crispin A, et al. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the transplantation center munich. Kidney Int. 2007;71:1271\u20138. https:\/\/doi.org\/10.1038\/sj.ki.5002154.","journal-title":"Kidney Int"},{"key":"3839_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103754","volume":"177","author":"MP Rollan","year":"2022","unstructured":"Rollan MP, Cabrera R, Schwartz RA. Current knowledge of immunosuppression as a risk factor for skin cancer development. Crit Rev Oncol Hematol. 2022;177: 103754. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103754.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3839_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jocn.2021.03.015","volume":"88","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Wang M, Xu L, et al. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: a systematic review and meta-analysis. Journal of Clinical Neuroscience. 2021;88:70\u20134. https:\/\/doi.org\/10.1016\/j.jocn.2021.03.015.","journal-title":"Journal of Clinical Neuroscience"},{"key":"3839_CR54","unstructured":"Mohammadi O, Kassim TA (2024) Azathioprine. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"3839_CR55","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/ard.47.12.988","volume":"47","author":"AJ Silman","year":"1988","unstructured":"Silman AJ, Petrie J, Hazleman B, Evans SJ. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis. 1988;47:988\u201392. https:\/\/doi.org\/10.1136\/ard.47.12.988.","journal-title":"Ann Rheum Dis"},{"key":"3839_CR56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1684\/ejd.2021.4108","volume":"31","author":"JAG Gibson","year":"2021","unstructured":"Gibson JAG, Cordaro A, Dobbs TD, et al. The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients. Eur J Dermatol. 2021;31:712\u201321. https:\/\/doi.org\/10.1684\/ejd.2021.4108.","journal-title":"Eur J Dermatol"},{"key":"3839_CR57","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-6143.2011.03751.x","volume":"12","author":"GFL Hofbauer","year":"2012","unstructured":"Hofbauer GFL, Attard NR, Harwood CA, et al. Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant. 2012;12:218\u201325. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03751.x.","journal-title":"Am J Transplant"},{"key":"3839_CR58","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1111\/ajt.13863","volume":"16","author":"Z Jiyad","year":"2016","unstructured":"Jiyad Z, Olsen CM, Burke MT, et al. Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis. Am J Transplant. 2016;16:3490\u2013503. https:\/\/doi.org\/10.1111\/ajt.13863.","journal-title":"Am J Transplant"},{"key":"3839_CR59","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.healun.2006.06.010","volume":"25","author":"JO O\u2019Neill","year":"2006","unstructured":"O\u2019Neill JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the international society for heart and lung transplantation. J Heart Lung Transplant. 2006;25:1186\u201391. https:\/\/doi.org\/10.1016\/j.healun.2006.06.010.","journal-title":"J Heart Lung Transplant"},{"key":"3839_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000001006","author":"M Kreuz","year":"2025","unstructured":"Kreuz M, de Moraes FCA, Sano VKT, et al. Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1\/PD-L1 blockade: a systematic review and meta-analysis. Melanoma Res. 2025. https:\/\/doi.org\/10.1097\/CMR.0000000000001006.","journal-title":"Melanoma Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03839-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03839-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T10:35:36Z","timestamp":1750329336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03839-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3839"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03839-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication and Informed consent"}}]}}